Integra LifeSciences Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Integra LifeSciences (IART) Tops Q2 EPS by 23c
August 10, 2020 4:22 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.33, $0.23 better than the analyst estimate of $0.10. Revenue for the quarter came in at $258.7 million versus the consensus estimate of $242.8 million.
The Company's full-year 2020 guidance remains withdrawn due to the uncertainty related to COVID-19 and... More



